PMID- 27125825 OWN - NLM STAT- MEDLINE DCOM- 20170713 LR - 20170817 IS - 1432-0738 (Electronic) IS - 0340-5761 (Linking) VI - 91 IP - 2 DP - 2017 Feb TI - The long persistence of pyrrolizidine alkaloid-derived DNA adducts in vivo: kinetic study following single and multiple exposures in male ICR mice. PG - 949-965 LID - 10.1007/s00204-016-1713-z [doi] AB - Pyrrolizidine alkaloid (PA)-containing plants are widespread in the world and the most common poisonous plants affecting livestock, wildlife, and humans. Our previous studies demonstrated that PA-derived DNA adducts can potentially be a common biological biomarker of PA-induced liver tumor formation. In order to validate the use of these PA-derived DNA adducts as a biomarker, it is necessary to understand the basic kinetics of the PA-derived DNA adducts formed in vivo. In this study, we studied the dose-dependent response and kinetics of PA-derived DNA adduct formation and removal in male ICR mice orally administered with a single dose (40 mg/kg) or multiple doses (10 mg/kg/day) of retrorsine, a representative carcinogenic PA. In the single-dose exposure, the PA-derived DNA adducts exhibited dose-dependent linearity and persisted for up to 4 weeks. The removal of the adducts following a single-dose exposure to retrorsine was biphasic with half-lives of 9 h (t (1/2alpha)) and 301 h (~12.5 days, t (1/2beta)). In the 8-week multiple exposure study, a marked accumulation of PA-derived DNA adducts without attaining a steady state was observed. The removal of adducts after the multiple exposure also demonstrated a biphasic pattern but with much extended half-lives of 176 h (~7.33 days, t (1/2alpha)) and 1736 h (~72.3 days, t (1/2beta)). The lifetime of PA-derived DNA adducts was more than 8 weeks following the multiple-dose treatment. The significant persistence of PA-derived DNA adducts in vivo supports their role in serving as a biomarker of PA exposure. FAU - Zhu, Lin AU - Zhu L AD - School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China. AD - Joint Research Laboratory of Promoting Globalization of Traditional Chinese Medicines Between The Chinese University of Hong Kong and Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China. FAU - Xue, Junyi AU - Xue J AD - School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China. AD - Joint Research Laboratory of Promoting Globalization of Traditional Chinese Medicines Between The Chinese University of Hong Kong and Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China. FAU - Xia, Qingsu AU - Xia Q AD - National Center for Toxicological Research, Jefferson, AR, 72079, USA. FAU - Fu, Peter P AU - Fu PP AD - National Center for Toxicological Research, Jefferson, AR, 72079, USA. peter.fu@fda.hhs.gov. FAU - Lin, Ge AU - Lin G AD - School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China. linge@cuhk.edu.hk. AD - Joint Research Laboratory of Promoting Globalization of Traditional Chinese Medicines Between The Chinese University of Hong Kong and Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China. linge@cuhk.edu.hk. LA - eng PT - Journal Article DEP - 20160428 PL - Germany TA - Arch Toxicol JT - Archives of toxicology JID - 0417615 RN - 0 (DNA Adducts) RN - 0 (Pyrrolizidine Alkaloids) RN - XJ86XWL8IY (retrorsine) SB - IM MH - Administration, Oral MH - Animals MH - DNA Adducts/*metabolism MH - Dose-Response Relationship, Drug MH - Liver/drug effects/pathology MH - Male MH - Mice, Inbred ICR MH - Pyrrolizidine Alkaloids/administration & dosage/*toxicity OTO - NOTNLM OT - Biomarker OT - DNA adducts OT - Kinetics OT - Pyrrolizidine alkaloid EDAT- 2016/04/30 06:00 MHDA- 2017/07/14 06:00 CRDT- 2016/04/30 06:00 PHST- 2016/01/05 00:00 [received] PHST- 2016/04/14 00:00 [accepted] PHST- 2016/04/30 06:00 [pubmed] PHST- 2017/07/14 06:00 [medline] PHST- 2016/04/30 06:00 [entrez] AID - 10.1007/s00204-016-1713-z [pii] AID - 10.1007/s00204-016-1713-z [doi] PST - ppublish SO - Arch Toxicol. 2017 Feb;91(2):949-965. doi: 10.1007/s00204-016-1713-z. Epub 2016 Apr 28.